Results 61 to 70 of about 2,425 (160)

Impact of Renin–Angiotensin–Aldosterone System (RAAS) Gene Polymorphism in Essential Hypertension and Antihypertensive Drug Therapy: A Review

International Journal of Hypertension, Volume 2025, Issue 1, 2025.
Genetic, demographic and environmental factors all play a role in the frequency of an intricate multifactorial condition known as hypertension. Approximately 30% and 50% of BP fluctuation are influenced by genetic variability. Many genetic studies have confirmed the link between genetic variability and susceptibility to essential hypertension; hence ...
Archana Adhikari, Chandrakala Sharma, Mingma Lhamu Sherpa, Gauthaman Karaunakran, Mona Dhakal, Anita Sharma, Nidhi Chaudhary   +6 more
wiley   +1 more source

Fosinopril improves liver fibrosis by upregulating ACE2/Angiotensin-(1-7) axis activation in rats with nonalcoholic steatohepatitis [PDF]

, 2012
The aim of this research was to evaluate the effect of the angiotensin converting enzyme (ACE) inhibitor fosinopril on liver fibrosis in rats with high fat diet (HFD) induced nonalcoholic steatohepatitis (NASH).
Xiao, Xiaoqiu, Liu, Bo, Wu, Rong, Zhang, Wei, Zhou, Huamei, Wang, Lulu, Wu, Xiaoling, Zhang, Xia, Zhang, Feng   +8 more
core  

A Clinical Study on the Anti-Hypertensive Efect of Fosinopril in Mild to Moderate Hypertensive Patients

, 1994
Background: The angiotensin-converting enzyme inhibitors have been found to be safe and efficacious in the treatment of essential hypertension. Fosinopril is the first angiotensin-converting enzyme inhibitor from a new class of agents containing ...
하종원
core   +1 more source

Polypharmacy and Potential Drug–Drug Interactions in Patients With Atrial Fibrillation

Journal of Clinical Pharmacy and Therapeutics, Volume 2025, Issue 1, 2025.
What is Known and Objective: The use of multiple medications, or polypharmacy, is associated with an elevated risk of potential drug–drug interactions (pDDIs), consequently heightening the probability of adverse drug reactions. Currently, there is a dearth of data regarding pDDIs in Chinese patients with atrial fibrillation (AF) within real‐world ...
Ying Bai, Jianqi Wang, Guangyao Li, Zhen Zhou, Nicholas B. Norgard   +4 more
wiley   +1 more source

Rediscovery of the implication of albuminuria in heart failure: emerging classic index for cardiorenal interaction

ESC Heart Failure, Volume 11, Issue 6, Page 3470-3487, December 2024.
Abstract The development of new drugs and device therapies has led to remarkable advancements in heart failure (HF) treatment in the past couple of decades. However, it becomes increasingly evident that guideline‐directed medical therapy cannot be one‐size‐fits‐all across a wide range of ejection fractions (EFs) and various aetiologies.
Kyung‐Duk Min, Yuki Matsumoto, Masanori Asakura, Masaharu Ishihara   +3 more
wiley   +1 more source

Influence of asilsartan medoxomile on arterial hypertension variability in patients with arterial hypertension and chronic obstructive pulmonary disease

Лечащий Врач, 2021
We studied hypotensive effects, as well as short-term, daily and long-term variability of arterial pressure against the background of treatment with angiotensin-transforming ferment inhibitor and angiotensin-ferment blockers II in patients with arterial ...
N. Yu. Grigorieva, M. E. Koroleva
doaj  

Reductions in renin‐angiotensin system inhibitors following hospitalization for heart failure

ESC Heart Failure, Volume 11, Issue 6, Page 3862-3871, December 2024.
Abstract Aims Limited data are available that evaluate the efficacy of renin‐angiotensin system inhibitor (RASI) dose‐reduction in older adults with heart failure with reduced ejection fraction following a heart failure hospitalization. Methods and results We examined a 5% random sample of Medicare beneficiaries with prescription coverage who were ...
Parag Goyal, Ligong Chen, Jennifer D. Lau, Robert S. Rosenson, Emily B. Levitan   +4 more
wiley   +1 more source

Datasheet1_Efficacy of fosinopril and amlodipine in pediatric primary hypertension: a single-center observational study.docx

, 2023
ObjectiveFosinopril and amlodipine are commonly prescribed as first-line pharmacotherapeutic agents for pediatric hypertension, but there is a lack of comparative studies regarding the efficacy of these two drugs.
Wenquan Niu (118888), Yaqi Li (2936265), Hui Wang (30400), Yao Lin (1622536), Lin Shi (65217), Yuting Wang (434390)   +5 more
core   +1 more source

Histological Study on the Possible Protective Effect of Probiotics versus Fosinopril in a Rat Model of Myocardial Infarction

The Egyptian Journal of Histology
Introduction: Myocardial infarction (MI) is major health issue implicated in high rates of mortality globally. Fosinopril is an angiotensin converting enzyme inhibitor (ACE-I) which is linked to ameliorating cardiovascular disorders.
seham AbdElhamid Mohamed elkalawy, Dina Mohamed Radwan, Shimaa Mohsen Emam, Manal Ali Abdel Mohsen   +3 more
doaj   +1 more source

EFFECT OF ACE INHIBITOR AND RECEPTOR ANTAGONIST OF TYPE 1 ANGIOTENSIN II ON HEMODYNAMICS AND MORPHO-FUNCTIONAL PARAMETERS OF THE HEART IN PATIENTS WITH HEART FAILURE ON A BACKGROUND OF CORONARY HEART DISEASE COMBINED WITH TYPE 2 DIABETES

Кубанский научный медицинский вестник, 2017
Aim. The article discusses the evaluation of the effect of 3-month therapy of angiotensin-converting enzyme fosinopril and angiotensin II receptor antagonists valsartan on the clinical manifestations of CHF, hemodynamics and morphofunctional parameters ...
Z. V. BITAROVA, O. V. REMIZOV, Z. T. ASTAKHOVА   +2 more
doaj   +1 more source